Insmed Incorporated Provides Sales Guidance for the Full Year 2023 and 2024
The company anticipates 2024 global ARIKAYCE revenues to be between $340 million and $360 million, representing 15% year-over-year growth at the midpoint compared to 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.3 USD | +2.04% | +5.37% | -18.02% |
1st Jan change | Capi. | |
---|---|---|
-18.02% | 3.68B | |
-2.32% | 103B | |
+1.90% | 95.28B | |
+1.60% | 22.15B | |
-15.40% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-12.85% | 16.05B | |
+4.42% | 13.68B | |
+35.50% | 12.17B |